NEW YORK, Aug 7 – Amersham Pharmacia of London said Tuesday its Amersham Pharmacia Biotech unit posted overall sales of 325.1 million pounds ($460.2 million) in the first half of the year, up 13 percent from the same period a year ago.

Within APBiotech, the company reported a 22 percent increase in its protein purification separations business to 130 million pounds, a one percent increase in sales of laboratory products to 93 million pounds, and a nine percent increase in drug discovery sales to 71 million pounds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.